A transdiagnostic approach of negative symptoms in psychiatric disorders: replication of a two-factor structure in major depressive disorder and bipolar disorder

被引:1
|
作者
Li, Shuai-Biao [1 ]
Zhang, Jian-Biao [2 ]
Liu, Chao [2 ]
Wang, Ling-Ling [3 ,4 ,5 ]
Hu, Hui-Xin [3 ,4 ,6 ]
Chu, Min-Yi [1 ]
Wang, Yi [3 ,4 ]
Lv, Qin-Yu [1 ,7 ]
Lui, Simon S. Y. [8 ]
Yi, Zheng-Hui [1 ,7 ,9 ]
Chan, Raymond C. K. [3 ,4 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, 600 South Wanping Rd, Shanghai, Peoples R China
[2] Nantong Fourth Peoples Hosp, Nantong, Jiangsu, Peoples R China
[3] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, 16 Lincui Rd, Beijing, Peoples R China
[4] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
[5] Shanghai Normal Univ, Sch Psychol, Shanghai, Peoples R China
[6] Beijing Forestry Univ, Sch Humanities & Social Sci, Dept Psychol, Beijing, Peoples R China
[7] Fudan Univ, Huashan Hosp, Sch Med, Dept Psychiat, Shanghai, Peoples R China
[8] Univ Hong Kong, Sch Clin Med, Dept Psychiat, Hong Kong, Peoples R China
[9] Fudan Univ, Inst Mental Hlth, Shanghai, Peoples R China
关键词
Negative symptoms; Transdiagnostic; Latent structure; Major depressive disorder; Bipolar disorder; CLINICAL-ASSESSMENT INTERVIEW; OF-FIT INDEXES; SCHIZOPHRENIA; SCALE; INDIVIDUALS; DIMENSIONS; VALIDITY; APATHY;
D O I
10.1007/s00406-024-01934-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent empirical findings suggest that negative symptoms are not limited to schizophrenia (SCZ) but also present in major depressive disorder (MDD) and bipolar disorder (BD) patients. Although SCZ patients generally showed a latent structure comprising the motivation and pleasure (MAP) and expression (EXP) factors, it remains unclear whether the same latent structure exists in MDD and BD patients. We administered the Clinical Assessment Interview for Negative Symptoms (CAINS) and the Brief Negative Symptom Scale (BNSS) to 179 MDD patients and 152 BD patients. Confirmatory Factor Analysis (CFA) was conducted to examine the one-factor model, the two-factor model of the MAP and the EXP domain, the five-factor model of anhedonia, avolition, asociality, alogia, and blunted affect, and the hierarchical model comprising the first-order five-factor, and the second-order two-factor (MAP and EXP factors). We further examined the correlations between demographics and the negative symptom dimensions found in the best factor model. The CFA showed that, when the CAINS and the BNSS were combined together, the two-factor model of MAP and EXP provided the best model fit than other competing models, in the MDD alone sample, BD alone sample, and the combined clinical sample. The two-factor model of the MAP and EXP appears to be a stable, transdiagnostic latent structure of negative symptoms across BD and MDD. Clarifying negative symptoms in MDD and BD can facilitate future research on the underlying neural mechanisms of the MAP and EXP dimensions.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] A transdiagnostic approach to negative symptoms: exploring factor structure and negative symptoms in bipolar disorders
    Ihler, Henrik Myhre
    Lyngstad, Siv Hege
    Morch-Johnsen, Lynn Egeland
    Lagerberg, Trine Vik
    Melle, Ingrid
    Romm, Kristin Lie
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [2] Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
    Yang, Qingxia
    Xing, Qiaowen
    Yang, Qingfang
    Gong, Yaguo
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 5054 - 5064
  • [3] A transdiagnostic comparison of affective decision-making in patients with schizophrenia, major depressive disorder, or bipolar disorder
    Gu, Yu-ting
    Zhou, Chen
    Yang, Juan
    Zhang, Qin
    Zhu, Guo-hui
    Sun, Lin
    Ge, Mao-hong
    Wang, Yan-yu
    PSYCH JOURNAL, 2020, 9 (02) : 199 - 209
  • [4] Transdiagnostic and Illness-Specific Functional Dysconnectivity Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
    Huang, Chu-Chung
    Luo, Qiang
    Palaniyappan, Lena
    Yang, Albert C.
    Hung, Chia-Chun
    Chou, Kun-Hsien
    Lo, Chun-Yi Zac
    Liu, Mu-N
    Tsai, Shih-Jen
    Barch, Deanna M.
    Feng, Jianfeng
    Lin, Ching-Po
    Robbins, Trevor W.
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2020, 5 (05) : 542 - 553
  • [5] Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles
    Tao, Shiwan
    Zhang, Yamin
    Wang, Qiang
    Qiao, Chunxia
    Deng, Wei
    Liang, Sugai
    Wei, Jinxue
    Wei, Wei
    Yu, Hua
    Li, Xiaojing
    Li, Mingli
    Guo, Wanjun
    Ma, Xiaohong
    Zhao, Liansheng
    Li, Tao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [6] Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder
    McIntyre, Roger S.
    Rosenbluth, Michael
    Ramasubbu, Rajamannar
    Bond, David J.
    Taylor, Valerie H.
    Beaulieu, Serge
    Schaffer, Ayal
    ANNALS OF CLINICAL PSYCHIATRY, 2012, 24 (02) : 163 - 169
  • [7] Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia
    Stein, Frederike
    Lemmer, Gunnar
    Schmitt, Simon
    Brosch, Katharina
    Meller, Tina
    Fischer, Elena
    Kraus, Cynthia
    Lenhard, Lutz
    Koehnlein, Birgit
    Murata, Harumi
    Baecker, Achim
    Mueller, Matthias
    Franz, Michael
    Foerster, Katharina
    Meinert, Susanne
    Enneking, Verena
    Koch, Katharina
    Grotegerd, Dominik
    Nagels, Arne
    Nenadic, Igor
    Dannlowski, Udo
    Kircher, Tilo
    Krug, Axel
    SCHIZOPHRENIA RESEARCH, 2020, 218 : 38 - 47
  • [8] The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder
    Mandelli, Laura
    Wang, Sheng-Min
    Han, Changsu
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Pae, Chi-Un
    Serretti, Alessandro
    ADVANCES IN THERAPY, 2017, 34 (03) : 713 - 724
  • [9] Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study
    Correa-Ghisays, Patricia
    Vicent Sanchez-Orti, Joan
    Balanza-Martinez, Vicent
    Selva-Vera, Gabriel
    Vila-Frances, Joan
    Magdalena-Benedito, Rafael
    Victor, Victor M.
    Escribano-Lopez, Irene
    Hernandez-Mijares, Antonio
    Vivas-Lalinde, Juliana
    San-Martin, Constanza
    Crespo-Facorro, Benedicto
    Tabares-Seisdedos, Rafael
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 300 : 99 - 108
  • [10] Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
    Shin, Dongyoon
    Rhee, Sang Jin
    Shin, Daun
    Joo, Eun-Jeong
    Jung, Hee Yeon
    Roh, Sungwon
    Lee, Sang-Hyuk
    Kim, Hyeyoung
    Bang, Minji
    Lee, Kyu Young
    Kim, Se Hyun
    Lee, Jihyeon
    Kim, Yoseop
    Yeo, Injoon
    Kim, Yeongshin
    Kim, Jaenyeon
    Kwon, Jun Soo
    Ha, Kyooseob
    Ahn, Yong Min
    Kim, Youngsoo
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (06):